Literature DB >> 7704941

Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease.

C H Konings1, M A Kuiper, P L Bergmans, A M Grijpma, G J van Kamp, E C Wolters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7704941     DOI： 10.1016/0009-8981(94)90259-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  12 in total

Review 1.  Cognitive impairment and dementia in patients with Parkinson disease.

Authors:  James B Leverenz; Joseph F Quinn; Cyrus Zabetian; Jing Zhang; Kathleen S Montine; Thomas J Montine
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

2.  Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Begoña Villar-Cheda; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Maria J Guerra
Journal:  Aging Dis       Date:  2011-04-20       Impact factor: 6.745

3.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

4.  Nox4-generated superoxide drives angiotensin II-induced neural stem cell proliferation.

Authors:  Elena Topchiy; Evgeniy Panzhinskiy; W Sue T Griffin; Steven W Barger; Mita Das; W Michael Zawada
Journal:  Dev Neurosci       Date:  2013-06-08       Impact factor: 2.984

5.  The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.

Authors:  Patricia K Sonsalla; Christal Coleman; Lai-Yoong Wong; Suzan L Harris; Jason R Richardson; Bharathi S Gadad; Wenhao Li; Dwight C German
Journal:  Exp Neurol       Date:  2013-10-30       Impact factor: 5.330

Review 6.  Environmental estrogen-like chemicals and hydroxyl radicals induced by MPTP in the striatum: a review.

Authors:  Toshia Obata
Journal:  Neurochem Res       Date:  2002-05       Impact factor: 3.996

7.  Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra.

Authors:  Pablo Garrido-Gil; Rita Valenzuela; Begoña Villar-Cheda; Jose L Lanciego; Jose L Labandeira-Garcia
Journal:  Brain Struct Funct       Date:  2012-03-11       Impact factor: 3.270

8.  Role of vitamin d in Parkinson's disease.

Authors:  Khanh L Ng; Lan Nguyễn
Journal:  ISRN Neurol       Date:  2012-03-07

Review 9.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

10.  Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson's disease.

Authors:  Qing Gao; Zhou Ou; Teng Jiang; You-Yong Tian; Jun-Shan Zhou; Liang Wu; Jian-Quan Shi; Ying-Dong Zhang
Journal:  Oncotarget       Date:  2017-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.